Introduction {#s1}
============

Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease with symmetric inflammation of aggressive multiple joints ([@B48]). As the most common inflammatory rheumatic disease, the prevalence of RA is about 0.5%-1.0% in the world ([@B44]). The inflammatory cell infiltration of synovium, pannus formation, and the progressive destruction of articular cartilage and bone destruction are the main pathological properties of RA ([@B4]). The data from epidemiological investigations shows that about 90% of RA patients developed bone erosions within 2 years, eventually leading to joint deformities or even disability ([@B6]). Therefore, RA brings great impact on the quality of life of patients and also imposes a heavy burden on families and society.

Traditional Chinese medicine (TCM) has the advantages of definite curative effect, safety and few side effects in the treatment of rheumatoid arthritis and has attracted more and more attention in the prevention and treatment of rheumatoid arthritis. TCM usually treats RA and other complex diseases in the form of formulas, which has theoretical advantages and rich clinical experience. In the study of RA therapy-related formulas, increasing evidence confirmed that different formulas can treat RA, which coincide with the theoretical concept of "treating the same disease with different treatments" in TCM ([@B15]). Such as Danggui-Sini-decoction (DSD) ([@B2]), Guizhi-Fuzi-decoction (GFD) ([@B40]), and Huangqi-Guizhi Wuwu-Decoction (HGWD) ([@B53]) etc., have been found successful in controlling RA in TCM clinics. Previous pharmacological studies have shown that DSD exert positive effects and good anti-inflammatory function which might protect collagen-induced arthritis rats from bone and cartilage destruction ([@B9]). It has been reported that GFD could substantially inhibit the activities of interleukin-6 and tumor necrosis factor-α in the serum of adjuvant-induced arthritis rats, as well as inhibit the formation of synovitis and pannus, and has obvious therapeutic effect on rheumatoid arthritis ([@B21]; [@B55]). In addition, some pharmacological experimental studies have found that HGWD could promote the apoptosis of synovial cells in rheumatoid arthritis rats with abnormal hyperfunction ([@B31]), and reduce the degree of foot swelling in adjuvant arthritis rats, affect the arthritis index of rats, and play a role in treating rheumatoid arthritis ([@B46]).

In these formulas, DSD consists of 7 herbs: *Angelica sinensis* (Oliv.) Diels (Danggui, 12 g), *Cinnamomum cassia* (L.) J. Presl (Cinnamomi ramulus, Guizhi, 9 g), *Paeonia lactiflora* Pall. (Baishao, 9 g), *Asarum sieboldii* Miq. (Xixin, 3 g), *Glycyrrhiza uralensis* Fisch. ex DC. (Gancao, 6 g), *Tetrapanax papyrifer* (Hook.) K. Koch (Medulla tetrapanacis, Tongcao, 6 g), *Ziziphus jujuba* Mill. (Jujubae fructus, Dazao, 8). GFD consists of 5 herbs: *Cinnamomum cassia* (L.) J. Presl (Cinnamomi ramulus, Guizhi, 12 g), *Aconitum carmichaeli* Debeaux (Aconiti lateralis radix praeparata, Fuzi, 15 g), *Zingiber officinale* Roscoe (Shengjiang, 9 g), *Glycyrrhiza uralensis* Fisch. ex DC. (Gancao, 6 g), *Ziziphus jujuba* Mill. (Jujubae fructus, Dazao, 12). HGWD consists of 5 herbs: *Astragalus mongholicus* Bunge (Huangqi, 15 g), *Paeonia lactiflora* Pall. (Baishao, 12 g), *Cinnamomum cassia* (L.) J. Presl (Cinnamomi ramulus, Gui zhi, 12 g), *Zingiber officinale* Roscoe (Shengjiang, 25 g), *Ziziphus jujuba* Mill. (Jujubae fructus, Dazao, 4). These traditional formulas are recorded in the Chinese pharmacopoeia ([@B38]). However, the molecular mechanism of these different formulas in treating rheumatoid arthritis under the concept of "treating the same disease with different treatments" is still unclear. How to develop new methods to detect the key component groups of different formulas for treating rheumatoid arthritis and speculate the possible mechanism not only provides the benefit therapy strategy for the precise treatment of RA, but also provides methodological reference for the analysis of the mechanism of treating the same disease with different treatments in TCM.

Network pharmacology has been widely used in the research of treating the same diseases with different formulas. For example, Gao et al. used network pharmacology to decode the mechanisms of Xiaoyao powder and Kaixin powder in treating depression; Liu et al. clarified the molecular mechanism of Sini San and Suanzaoren Tang in treating insomnia based on network pharmacology, etc ([@B61]; [@B32]). With the in-depth intersection of systems biology, poly-pharmacology, bioinformatics and other technologies, and the continuous improvement of the accuracy, reliability, and integrity of data resources, the research ideas and technical means of network pharmacology will be better applied to the mechanism research of formulas in TCM and provide more innovation in methodology for the molecular level research of TCM.

In this study, network pharmacology model was applied to analyze the key gene network motif with significant (KNMS) of different formulas in the treatment of RA. Coverage of RA pathogenic genes, coverage of functional pathways and cumulative contribution of key nodes were employed to evaluate the accuracy and reliability of KNMSs, and then the validated KNMSs were used to infer the common potential mechanism of different formulas in the treatment of RA. In summary, the proposed network pharmacology strategy aims to identify major mechanism and related pharmacological effects of different treatments in treating RA through specific KNMSs, which may offer a new network-based method for evaluating and selecting suitable treatment strategies of complex diseases in TCM.

Materials and Methods {#s2}
=====================

Flowchart {#s2_1}
---------

This phenomenon that different formulas treat the same diseases is widely used in TCM clinical applications. However, there is lack of systematic method to decode the mechanisms of treat the same disease with different treatments. In this study, we designed a network pharmacology model to decode the common and specific potential mechanisms of 3 formulas in the treatment of RA, which may provide a methodological reference for different formulas treat the same disease. The workflow is illustrated in [**Figure 1**](#f1){ref-type="fig"} and described as follows: 1) the components of DSD, GFD and HGWD were collected from TCMSP, TCMID, and TCM\@Taiwan; 2) ADME based methods were used to identify the main active components; 3) the main active components from three formulas and their predicted targets were used to construct the component-target (C-T) networks; 4) The KNMSs were detected from integrated C-T and target-target interaction networks; 5) the KNMSs were validated by the coverage of RA pathogenic genes, coverage of functional pathways and cumulative contribution of key nodes; 6) Finally, all validated KNMSs were employed to decode the underlying mechanism of different formulas treat the same disease.

![A schematic diagram of network pharmacology-based strategy to decode the mechanisms of different formulas treat the same disease of TCM. DSD represents Danggui-Sini-decoction, GFD represents Guizhi-Fuzi-decoction, and HGWD represents Huangqi-Guizhi Wuwu-Decoction, KNMSs represents key gene network motifs with significant.](fphar-11-01035-g001){#f1}

Component Identification {#s2_2}
------------------------

All chemical components of Danggui-Sini-decoction (DSD), Guizhi-Fuzi-decoction (GFD), and Huangqi-Guizhi Wuwu-Decoction (HGWD) were collected from Traditional Chinese Medicine Systems Pharmacology (TCMSP) Database ([@B42]) (<http://lsp.nwsuaf.edu.cn/tcmsp.php>), Traditional Chinese Medicine integrated database ([@B59]) (TCMID, <http://www.megabionet.org/tcmid/>), and TCM\@Taiwan ([@B7]) (<http://tcm.cmu.edu.tw/zh-tw>). The chemical identification and concentration of the herbs in DSD, GFD, and HGWD were collected from the previous reports. All chemical structures were prepared and converted into canonical SMILES using Open Babel Toolkit (version 2.4.1). The targets of DSD, GFD, and HGWD were predicted by using Similarity Ensemble Approach SEA ([@B25]) (<http://sea.bkslab.org/>) and Swiss Target Prediction ([@B13]) (<http://www.swisstargetprediction.ch/>).

ADME Screening {#s2_3}
--------------

Components that meet the Lipinski' rules of five usually have better pharmacokinetic properties, higher bioavailability during metabolism in the body, and are therefore more likely to be drug candidates ([@B29]; [@B12]). Oral bioavailability (OB) refers to the extent and rate of active components release from the herbs into the systemic circulation and is an important indicator for evaluating the intrinsic quality of the component ([@B58]). Drug-like (DL) indicate the characteristics that an ideal drug should have and was a comprehensive reflection of the physical and chemical properties and structural characteristics exhibited by successful drugs ([@B50]). In this study, active components from DSD, GFD, and HGWD were mainly filtered by integrating Lipinski's rules, oral bioavailability (OB), and drug-likeness (DL). The detail of Lipinski's rules includes molecular weight lower than 500 Da, number of donor hydrogen bonds less than 5, number of acceptor hydrogen bonds less than 10, the log*P* lower than 5 and over -2, and meets only the criteria of 10 or fewer rotatable bonds. Besides, oral bioavailability (OB), and drug-likeness (DL) also were employed to screen the active components. The components with OB values higher than 30% and DL values higher than 0.14 were retained for further investigation ([@B52]).

Networks Construction {#s2_4}
---------------------

The component-target (C-T) networks of three formulas were constructed by using Cytoscape software (Version 3.7.0) ([@B33]). The topological parameters of networks were analyzed using Cytoscape plugin NetworkAnalyzer ([@B22]).

Detection of Key Gene Network Motif With Significant (KNMS) {#s2_5}
-----------------------------------------------------------

The exploration of motif structures in networks is an important issue in many domains and disciplines. To find key gene network motifs with significant (KNMS) of 3 formulas in the treatment of RA, a mathematical algorithm was designed and described as follows:

To take advantage of the motif structure of the network, *m motif codebooks,* and one index codebook are used to describe the random walker's movements within and between motifs, respectively. Motif codebook *i* has one codeword for each node *α∈i* and one exit codeword. The codeword lengths are derived from the frequencies at which the random walker visits each of the nodes in the motif, *p~α∈i~*, and exits the motif, *q* ~*i*↷~. We use *p* ~*i*↻~ to denote the sum of these frequencies, the total use of codewords in motif *i*, and *P^i^* to denote the normalized probability distribution. Similarly, the index codebook has codewords for motif entries. The codeword lengths are derived from the set of frequencies at which the random walker enters each motif, *q* ~*i*↶~. We use *q* ~↶~ to denote the sum of these frequencies, the total use of codewords to move into motifs, and *Q* to denote the normalized probability distribution. We want to express average length of codewords from the index codebook and the motif codebooks weighted by their rates of use. Therefore, the map equation is
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Below we explain the terms of the map equation in detail and we provide examples with Huffman codes for illustration.

*L*(M) represents the per-step description length for motif partition *M*. That is, for motif partition *M* of n nodes into *m* motifs, the lower bound of the average length of the code describing a step of the random walker.
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The rate at which the index codebook is used. The per-step use rate of the index codebook is given by the total probability that the random walker enters any of them motifs. This variable represents the proportion of all codes representing motif names in the codes. Where *q* ~*i*↶~ is probability of jumping out of Motif *i*.
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This variable represents the average byte length required to encode motif names. The frequency-weighted average length of codewords in the index codebook. The entropy of the relative rates to use the motif codebooks measures the smallest average codeword length that is theoretically possible. The heights of individual blocks under *Index codebook* correspond to the relative rates and the codeword lengths approximately correspond to the negative logarithm of the rates in base 2.
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This variable represents the coding proportion of all nodes (including jump-out nodes) belonging to motif *i* in the coding. The rate at which the motif codebook *i* is used, which is given by the total probability that any node in the motif is visited, plus the probability that the random walker exits the motif and the exit codeword is used.
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This variable represents the average byte length required to encode all nodes in motif *i*. The frequency-weighted average length of codewords in motif codebook *i*. The entropy of the relative rates at which the random walker exits motif *i* and visits each node in motif *i* measures the smallest average codeword length that is theoretically possible. The heights of individual blocks under motif codebooks correspond to the relative rates and the codeword lengths approximately correspond to the negative logarithm of the rates in base 2.

Contribution Coefficient Calculation {#s2_6}
------------------------------------

The contribution coefficient (CC) represents the network contribution of KNMSs in 3 formulas. R value was used to determine the importance of the components by the following mathematical model:
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where *d~c~* represents the degree of each component, which is calculated by Cytoscape. *R* is an indicator to evaluate the importance of the component.

Where n is the number of components from different KNMSs of DSD, GFD, and HGWD, respectively; m is the number of components from C-T network of DSD, GFD, and HGWD, respectively; *Ri* represents the indicator of each component in KNMSs of DSD, GFD, and HGWD, and *Rj* represents the indicator of each component in C-T network of DSD, GFD, and HGWD.

KEGG Pathway {#s2_7}
------------

To analyze the main function of the KNMSs, the pathway data were obtained from the Kyoto Encyclopedia of Genes and Genomes (KEGG) database ([@B14]) for KEGG pathway enrichment analyses. P-values were set at 0.05 as the cut-off criterion. The results of analysis were annotated by Pathview ([@B34]) in the R Bioconductor package (<https://www.bioconductor.org/>).

Experimental Validation {#s2_8}
-----------------------

### Materials {#s2_8_1}

Isoliquiritigenin, isorhamnetin and quercetin (≥98% purity by HPLC) was obtained from Chengdu Pufei De Biotech Co., Ltd (Chengdu, China). Fetal bovine serum (FBS) and Dulbecco's modified Eagle's medium (DMEM) were purchased from Gibco (Grand Island, USA). Lipopolysaccharide (LPS) was purchased from Sigma-Aldrich Co., Ltd (St Louis, USA).

### Cell Culture and Treatment {#s2_8_2}

RAW264.7 cells were obtained from the cell bank of the Chinese Academy of Sciences (Shanghai, China). The cells were cultured in DMEM with 10% FBS, and incubated at 37°C under 5% CO~2~. When RAW264.7 cells reached 80% confluency, the cells were treated with isoliquiritigenin, isorhamnetin and quercetin for 2 h, then the cells were treated with LPS (1 μg/ml) for 24 h.

### Cell Viability Assay {#s2_8_3}

MTT assay was utilized to measure cell viability. RAW264.7 cells (6×10^4^ per/well) were seeded in 96-well plates. After 24 h incubation, RAW264.7 cells were treated with 1, 5, 10, 20, 40, and 80 μM isoliquiritigenin, isorhamnetin and quercetin for 24 h. Ten μl of MTT were added to reach a final concentration of 0.5 mg/ml, and incubated for a further 4 h. The absorbance was measured at 570 nm with a microplate reader (BioTek, USA).

### Measurement of NO {#s2_8_4}

Griess reagent was utilized to detected the level of NO in the culture supernatant of RAW264.7 cells. After incubation with isoliquiritigenin, isorhamnetin and quercetin for 2 h and LPS (1 μg/ml) for 24 h, the culture supernatant was collected and mixed with Griess reagent for NO assay. The absorbance was measured at 540 nm using a microplate reader.

Statistical Analysis {#s2_9}
--------------------

To compare the importance of motifs in three formulas, SPSS22.0 was used for statistical analysis. One-way analysis of variance followed by a Dunnett post-hoc test was used to compare more than two groups. Obtained p-values were corrected by Benjamini-Hochberg false discovery rate (FDR). Results were considered as statistically significant if the p-value was \<0.05.

Results {#s3}
=======

Chemical Analysis {#s3_1}
-----------------

Chemical analysis plays important roles in the study of substances basis and mechanism of herbs in the formulas. By searching from the literature, we collected the information on specific chemical identification and concentration of the herbs in DSD, GFD and HGWD, respectively. The detail information was shown in [**Table 1**](#T1){ref-type="table"} and [**Table S1**](#SM1){ref-type="supplementary-material"}. The results suggest that chemical components of herbs and the concentration of identified components provide an experiment-aided chemical space for search of active components. This will provide valuable reference for the further analysis.

###### 

The information on chemical analysis of the herbs from the literature in DSD, GFD, and HGWD.

  Herb                                                                        Method        Component             Concentration   Formula          Ref.
  --------------------------------------------------------------------------- ------------- --------------------- --------------- ---------------- --------
  *Angelica sinensis* (Oliv.) Diels (Danggui)                                 HPLC          Ferulic acid          0.36 mg/g       DSD              [@B56]
  Coniferylferulate                                                           6.11 mg/g                                                            
  *Z*-ligustilide                                                             4.34 mg/g                                                            
  *E*-ligustilide                                                             0.23 mg/g                                                            
  *Z*-3-butylidenephthalide                                                   0.20 mg/g                                                            
  *E*-3-butylidenephthalide                                                   0.08 mg/g                                                            
  *Cinnamomum cassia* (L.) J. Presl (Cinnamomi ramulus, Guizhi)               UHPLC         Protocatechuic acid   0.11 mg/g       DSD, GFD, HGWD   [@B28]
  Coumarin                                                                    0.84 mg/g                                                            
  Cinnamic alcohol                                                            0.04 mg/g                                                            
  Cinnamic acid                                                               0.68 mg/g                                                            
  Cinnamaldehyde                                                              9.93 mg/g                                                            
  *Paeonia lactiflora* Pall. (Baishao)                                        HPLC          Gallic acid           2.33 mg/g       DSD, HGWD        [@B27]
  Hydroxyl-paeoniflorin                                                       1.89 mg/g                                                            
  Catechin                                                                    0.03 mg/g                                                            
  Albiflorin                                                                  4.44 mg/g                                                            
  Paeoniflorin                                                                4.81 mg/g                                                            
  Benzoic acid                                                                0.03 mg/g                                                            
  1, 2, 3, 4, 6 -pentagalloylglucose                                          4.80 mg/g                                                            
  Benzoyl -paeoniflorin                                                       0.11 mg/g                                                            
  Paeonol                                                                     0.07 mg/g                                                            
  *Asarum sieboldii* Miq. (Xixin)                                             HPLC          Aristolochic acid A   0.009 mg/g      DSD              [@B16]
  *Glycyrrhiza uralensis* Fisch. ex DC. (Gancao)                              HPLC          Glycyrrhizin          97.49 mg/g      DSD, GFD         [@B8]
  Liquiritin                                                                  102.83 mg/g                                                          
  Lsoliquritigenin                                                            98.30 mg/g                                                           
  *Tetrapanax papyrifer* (Hook.) K.Koch (Medulla tetrapanacis, Tongcao)       RP- HPLC      Calceolar ioside B    0.86 mg/g       DSD              [@B17]
  *Ziziphus jujuba* Mill. (Jujubae fructus (Dazao)                            HPLC          Rutin                 0.21 mg/g       DSD, GFD, HGWD   [@B54]
  Quercetin                                                                   0.008 mg/g                                                           
  Isorhamnetin                                                                0.17 mg/g                                                            
  *Aconitum carmichaeli* Debeaux (Aconiti lateralis radix praeparata, Fuzi)   HPLC          aconitine             0.28 mg/g       GFD              [@B49]
  hypaconitine                                                                0.70 mg/g                                                            
  mesaconitine                                                                1.04 mg/g                                                            
  benzoylaconine                                                              0.009 mg/g                                                           
  benzoylhypaconine                                                           0.007 mg/g                                                           
  benzoylmesaconin                                                            0.07 mg/g                                                            
  *Zingiber officinale* Roscoe (Shengjiang)                                   HPLC          6-Gingerol            16.62 mg/g      GFD, HGWD        [@B62]
  6-Shogaol                                                                   4.92 mg/g                                                            
  *Astragalus mongholicus* Bunge (Huangqi)                                    HPLC          Campanulin            0.42 mg/g       HGWD             [@B26]
  Formononetin                                                                0.02 mg/g                                                            

Active Components in DSD, GFD, and HGWD {#s3_2}
---------------------------------------

By a comprehensive search of the TCMSP, TCMID, and TCM\@Taiwan database, 812 components from seven herbs in DSD, 640 components from five herbs in GFD, and 459 components from five herbs in HGWD were obtained. A TCM formula usually contains large number of components, and ADME screening approaches are always used to select active components. After ADME screening, 124 active components in DSD, 120 active components in GFD, and 48 active components in HGWD were passed the combined filtering criteria which integrated by Lipinski's rule, OB, and DL ([**Table 2**](#T2){ref-type="table"}). For further analysis of these active components, 31 common components in three formulas and 93, 89, and 17 unique components in DSD, GFD, and HGWD were found ([**Figure 2**](#f2){ref-type="fig"}). These results indicate that three formulas might exert roles in treating RA by affecting the common components and specific components.

###### 

Components in DSD, GFD, and HGWD for further analysis after ADME screening.

  ID       Component                                                                                                                                                      MW       Logp    HDON   HACC   RBN   OB       DL     Source
  -------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- -------- ------- ------ ------ ----- -------- ------ ------------
  DSD1     (+)-catechin                                                                                                                                                   290.29   1.02    5      6      1     54.83    0.24   Baishao
  DSD2     (3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta \[a\]phenanthrene-15,16-dione                                 358.52   3.52    2      4      0     43.56    0.53   Baishao
  DSD3     11alpha,12alpha-epoxy-3beta-23-dihydroxy-30-norolean-20-en-28,12beta-olide                                                                                     470.71   3.82    2      5      1     64.77    0.38   Baishao
  DSD4     albiflorin_qt                                                                                                                                                  318.35   0.53    2      6      4     66.64    0.33   Baishao
  DSD5     kaempferol                                                                                                                                                     286.25   1.23    4      6      1     41.88    0.24   Baishao
  DSD6     Lactiflorin                                                                                                                                                    462.49   0.31    3      10     5     49.12    0.8    Baishao
  DSD7     paeoniflorgenone                                                                                                                                               318.35   0.86    1      6      4     87.59    0.37   Baishao
  DSD8     paeoniflorin_qt                                                                                                                                                318.35   0.69    2      6      4     68.18    0.4    Baishao
  DSD9     (-)-catechin                                                                                                                                                   290.29   1.02    5      6      1     49.68    0.24   Dazao
  DSD10    (S)-Coclaurine                                                                                                                                                 285.37   2.2     3      4      3     42.35    0.24   Dazao
  DSD11    21302-79-4                                                                                                                                                     486.76   4.53    3      5      3     73.52    0.77   Dazao
  DSD12    berberine                                                                                                                                                      336.39   3.75    0      4      2     36.86    0.78   Dazao
  DSD13    coumestrol                                                                                                                                                     268.23   2.43    2      5      0     32.49    0.34   Dazao
  DSD14    Fumarine                                                                                                                                                       353.4    1.95    0      6      0     59.26    0.83   Dazao
  DSD15    Jujubasaponin V_qt                                                                                                                                             472.78   4.61    2      4      2     36.99    0.63   Dazao
  DSD16    jujuboside A_qt                                                                                                                                                472.78   3.8     2      4      1     36.67    0.62   Dazao
  DSD17    Jujuboside C_qt                                                                                                                                                472.78   3.8     2      4      1     40.26    0.62   Dazao
  DSD18    malkangunin                                                                                                                                                    432.56   2.72    2      7      6     57.71    0.63   Dazao
  DSD19    Mauritine D                                                                                                                                                    342.46   1.11    2      6      2     89.13    0.45   Dazao
  DSD20    Moupinamide                                                                                                                                                    313.38   2.46    3      5      6     86.71    0.26   Dazao
  DSD21    Nuciferin                                                                                                                                                      295.41   3.38    0      3      2     34.43    0.4    Dazao
  DSD22    quercetin                                                                                                                                                      302.25   1.07    5      7      1     46.43    0.28   Dazao
  DSD23    Ruvoside_qt                                                                                                                                                    390.57   1.42    3      5      2     36.12    0.76   Dazao
  DSD24    Spiradine A                                                                                                                                                    311.46   1.29    1      3      0     113.52   0.61   Dazao
  DSD25    stepharine                                                                                                                                                     297.38   1.76    1      4      2     31.55    0.33   Dazao
  DSD26    Stepholidine                                                                                                                                                   327.41   2.26    2      5      2     33.11    0.54   Dazao
  DSD27    Ziziphin_qt                                                                                                                                                    472.78   3.8     2      4      1     66.95    0.62   Dazao
  DSD28    zizyphus saponin I_qt                                                                                                                                          472.78   3.8     2      4      1     32.69    0.62   Dazao
  DSD29    2,6-di(phenyl)thiopyran-4-thione                                                                                                                               280.43   4.39    0      0      2     69.13    0.15   Danggui
  DSD30    (-)-Medicocarpin                                                                                                                                               432.46   1.26    4      9      4     40.99    0.95   Gancao
  DSD31    (2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one                                                                                                                256.27   2.79    2      4      1     71.12    0.18   Gancao
  DSD32    (2S)-6-(2,4-dihydroxyphenyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro\[3,2-g\]chromen-7-one                                                          384.41   2.61    3      7      3     60.25    0.63   Gancao
  DSD33    (2S)-7-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one                                                                                         324.4    3.62    2      4      3     36.57    0.32   Gancao
  DSD34    (E)-1-(2,4-dihydroxyphenyl)-3-(2,2-dimethylchromen-6-yl)prop-2-en-1-one                                                                                        322.38   4.46    2      4      3     39.62    0.35   Gancao
  DSD35    (E)-3-\[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl\]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one                                                                    340.4    3.47    4      5      5     46.27    0.31   Gancao
  DSD36    1,3-dihydroxy-8,9-dimethoxy-6-benzofurano\[3,2-c\]chromenone                                                                                                   328.29   2.74    2      7      2     62.9     0.53   Gancao
  DSD37    1,3-dihydroxy-9-methoxy-6-benzofurano\[3,2-c\]chromenone                                                                                                       298.26   2.48    2      6      1     48.14    0.43   Gancao
  DSD38    18α-hydroxyglycyrrhetic acid                                                                                                                                   486.76   4.54    3      5      1     41.16    0.71   Gancao
  DSD39    1-Methoxyphaseollidin                                                                                                                                          354.43   3.66    2      5      3     69.98    0.64   Gancao
  DSD40    2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl)chromone                                                                                           354.38   2.99    4      6      3     44.15    0.41   Gancao
  DSD41    2-\[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano\[6,5-f\]chromen-3-yl\]-5-methoxyphenol                                                                             338.43   4.35    1      4      2     36.21    0.52   Gancao
  DSD42    3-(2,4-dihydroxyphenyl)-8-(1,1-dimethylprop-2-enyl)-7-hydroxy-5-methoxy-coumarin                                                                               368.41   3.92    3      6      4     59.62    0.43   Gancao
  DSD43    3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromone                                                                                           354.38   3.02    4      6      3     66.37    0.41   Gancao
  DSD44    3'-Hydroxy-4'-O-Methylglabridin                                                                                                                                354.43   3.76    2      5      2     43.71    0.57   Gancao
  DSD45    3'-Methoxyglabridin                                                                                                                                            354.43   3.76    2      5      2     46.16    0.57   Gancao
  DSD46    5,7-dihydroxy-3-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromone                                                                                               352.41   3.29    2      5      4     30.49    0.41   Gancao
  DSD47    6-prenylated eriodictyol                                                                                                                                       356.4    2.99    4      6      3     39.22    0.41   Gancao
  DSD48    7,2',4'-trihydroxy-5-methoxy-3-arylcoumarin                                                                                                                    300.28   2.51    3      6      2     83.71    0.27   Gancao
  DSD49    7-Acetoxy-2-methylisoflavone                                                                                                                                   294.32   3.41    0      4      3     38.92    0.26   Gancao
  DSD50    7-Methoxy-2-methyl isoflavone                                                                                                                                  266.31   3.48    0      3      2     42.56    0.2    Gancao
  DSD51    8-(6-hydroxy-2-benzofuranyl)-2,2-dimethyl-5-chromenol                                                                                                          308.35   4.27    2      4      1     58.44    0.38   Gancao
  DSD52    8-prenylated eriodictyol                                                                                                                                       356.4    2.99    4      6      3     53.79    0.4    Gancao
  DSD53    Calycosin                                                                                                                                                      284.28   2.82    2      5      2     47.75    0.24   Gancao
  DSD54    dehydroglyasperins C                                                                                                                                           340.4    3.11    4      5      3     53.82    0.37   Gancao
  DSD55    DFV                                                                                                                                                            256.27   2.79    2      4      1     32.76    0.18   Gancao
  DSD56    echinatin                                                                                                                                                      270.3    3.41    2      4      4     66.58    0.17   Gancao
  DSD57    Eurycarpin A                                                                                                                                                   338.38   3.29    3      5      3     43.28    0.37   Gancao
  DSD58    formononetin                                                                                                                                                   268.28   3.01    1      4      2     69.67    0.21   Gancao
  DSD59    Gancaonin A                                                                                                                                                    352.41   3.34    2      5      4     51.08    0.4    Gancao
  DSD60    Gancaonin B                                                                                                                                                    368.41   3.14    3      6      4     48.79    0.45   Gancao
  DSD61    Gancaonin G                                                                                                                                                    352.41   3.25    2      5      4     60.44    0.39   Gancao
  DSD62    Gancaonin H                                                                                                                                                    420.49   3.99    3      6      3     50.1     0.78   Gancao
  DSD63    Glabranin                                                                                                                                                      324.4    3.59    2      4      3     52.9     0.31   Gancao
  DSD64    Glabrene                                                                                                                                                       322.38   3.68    2      4      1     46.27    0.44   Gancao
  DSD65    Glabridin                                                                                                                                                      324.4    3.81    2      4      1     53.25    0.47   Gancao
  DSD66    Glabrone                                                                                                                                                       336.36   3.78    2      5      1     52.51    0.5    Gancao
  DSD67    Glepidotin A                                                                                                                                                   338.38   2.88    3      5      3     44.72    0.35   Gancao
  DSD68    Glepidotin B                                                                                                                                                   340.4    2.88    3      5      3     64.46    0.34   Gancao
  DSD69    glyasperin B                                                                                                                                                   370.43   3.14    3      6      4     65.22    0.44   Gancao
  DSD70    Glyasperin C                                                                                                                                                   356.45   3.53    3      5      4     45.56    0.4    Gancao
  DSD71    glyasperin F                                                                                                                                                   354.38   3.52    3      6      1     75.84    0.54   Gancao
  DSD72    Glyasperins M                                                                                                                                                  368.41   3.57    2      6      2     72.67    0.59   Gancao
  DSD73    Glycyrin                                                                                                                                                       382.44   3.78    2      6      5     52.61    0.47   Gancao
  DSD74    Glycyrol                                                                                                                                                       366.39   4.06    2      6      3     90.78    0.67   Gancao
  DSD75    Glycyrrhiza flavonol A                                                                                                                                         370.38   2.18    4      7      1     41.28    0.6    Gancao
  DSD76    Glypallichalcone                                                                                                                                               284.33   3.8     1      4      5     61.6     0.19   Gancao
  DSD77    Glyzaglabrin                                                                                                                                                   298.26   2.32    2      6      1     61.07    0.35   Gancao
  DSD78    HMO                                                                                                                                                            268.28   2.92    1      4      2     38.37    0.21   Gancao
  DSD79    Inermine                                                                                                                                                       284.28   2.19    1      5      0     75.18    0.54   Gancao
  DSD80    Inflacoumarin A                                                                                                                                                322.38   4.36    2      4      3     39.71    0.33   Gancao
  DSD81    Isoglycyrol                                                                                                                                                    366.39   4.15    1      6      1     44.7     0.84   Gancao
  DSD82    Isolicoflavonol                                                                                                                                                354.38   2.92    4      6      3     45.17    0.42   Gancao
  DSD83    isoliquiritigenin                                                                                                                                              256.27   3.04    3      4      3     85.32    0.15   Gancao
  DSD84    isorhamnetin                                                                                                                                                   316.28   1.31    4      7      2     49.6     0.31   Gancao
  DSD85    Isotrifoliol                                                                                                                                                   298.26   2.54    2      6      1     31.94    0.42   Gancao
  DSD86    Jaranol                                                                                                                                                        314.31   2.8     2      6      3     50.83    0.29   Gancao
  DSD87    kanzonols W                                                                                                                                                    336.36   3.97    2      5      1     50.48    0.52   Gancao
  DSD88    Licoagrocarpin                                                                                                                                                 338.43   3.94    1      4      3     58.81    0.58   Gancao
  DSD89    Licoagroisoflavone                                                                                                                                             336.36   2.95    2      5      2     57.28    0.49   Gancao
  DSD90    licochalcone a                                                                                                                                                 338.43   4.74    2      4      6     40.79    0.29   Gancao
  DSD91    Licochalcone B                                                                                                                                                 286.3    3.17    3      5      4     76.76    0.19   Gancao
  DSD92    licochalcone G                                                                                                                                                 354.43   4.21    3      5      6     49.25    0.32   Gancao
  DSD93    Licocoumarone                                                                                                                                                  340.4    4.1     3      5      4     33.21    0.36   Gancao
  DSD94    licoisoflavanone                                                                                                                                               354.38   3.54    3      6      1     52.47    0.54   Gancao
  DSD95    Licoisoflavone                                                                                                                                                 354.38   2.99    4      6      3     41.61    0.42   Gancao
  DSD96    Licoisoflavone B                                                                                                                                               352.36   3.54    3      6      1     38.93    0.55   Gancao
  DSD97    licopyranocoumarin                                                                                                                                             384.41   2.47    3      7      3     80.36    0.65   Gancao
  DSD98    Licoricone                                                                                                                                                     382.44   3.08    2      6      5     63.58    0.47   Gancao
  DSD99    liquiritin                                                                                                                                                     418.43   0.43    5      9      4     65.69    0.74   Gancao
  DSD100   Lupiwighteone                                                                                                                                                  338.38   3.23    3      5      3     51.64    0.37   Gancao
  DSD101   Medicarpin                                                                                                                                                     270.3    3.07    1      4      1     49.22    0.34   Gancao
  DSD102   naringenin                                                                                                                                                     272.27   2.47    3      5      1     59.29    0.21   Gancao
  DSD103   Odoratin                                                                                                                                                       314.31   2.81    2      6      3     49.95    0.3    Gancao
  DSD104   Phaseol                                                                                                                                                        336.36   4.59    2      5      2     78.77    0.58   Gancao
  DSD105   Phaseolinisoflavan                                                                                                                                             324.4    3.77    2      4      1     32.01    0.45   Gancao
  DSD106   Pinocembrin                                                                                                                                                    256.27   2.85    2      4      1     64.72    0.18   Gancao
  DSD107   Quercetin der.                                                                                                                                                 330.31   2.55    3      7      3     46.45    0.33   Gancao
  DSD108   Semilicoisoflavone B                                                                                                                                           352.36   3.55    3      6      1     48.78    0.55   Gancao
  DSD109   shinpterocarpin                                                                                                                                                322.38   4.13    1      4      0     80.3     0.73   Gancao
  DSD110   Sigmoidin-B                                                                                                                                                    356.4    3.02    4      6      3     34.88    0.41   Gancao
  DSD111   Vestitol                                                                                                                                                       272.32   2.89    2      4      2     74.66    0.21   Gancao
  DSD112   ent-Epicatechin                                                                                                                                                290.29   2.83    5      6      1     48.96    0.24   Guizhi
  DSD113   beta-sitosterol                                                                                                                                                414.79   3.2     1      1      6     36.91    0.75   Guizhi
  DSD114   sitosterol                                                                                                                                                     414.79   2.71    1      1      6     36.91    0.75   Guizhi
  DSD115   (-)-taxifolin                                                                                                                                                  304.27   1.66    5      7      1     60.51    0.27   Guizhi
  DSD116   DMEP                                                                                                                                                           282.32   1.93    0      6      10    55.66    0.15   Guizhi
  DSD117   paryriogenin A                                                                                                                                                 466.72   4.62    1      4      1     41.41    0.76   Tongcao
  DSD118   (3S)-7-hydroxy-3-(2,3,4-trimethoxyphenyl)chroman-4-one                                                                                                         330.36   1.59    1      6      4     48.23    0.33   Xixin
  DSD119   \[(1S)-3-\[(E)-but-2-enyl\]-2-methyl-4-oxo-1-cyclopent-2-enyl\] (1R,3R)-3-\[(E)-3-methoxy-2-methyl-3-oxoprop-1-enyl\]-2,2-dimethylcyclopropane-1-carboxylate   360.49   4.18    0      5      8     62.52    0.31   Xixin
  DSD120   4,9-dimethoxy-1-vinyl-\$b-carboline                                                                                                                            254.31   2.96    0      3      3     65.3     0.19   Xixin
  DSD121   Caribine                                                                                                                                                       326.43   0.53    2      5      0     37.06    0.83   Xixin
  DSD122   Cryptopin                                                                                                                                                      369.45   2.38    0      6      2     78.74    0.72   Xixin
  DSD123   sesamin                                                                                                                                                        354.38   2.25    0      6      2     56.55    0.83   Xixin
  DSD124   ZINC05223929                                                                                                                                                   354.38   2.25    0      6      2     31.57    0.83   Xixin
  GFD1     (-)-catechin                                                                                                                                                   290.29   1.02    5      6      1     49.68    0.24   Dazao
  GFD2     (+)-catechin                                                                                                                                                   290.29   1.02    5      6      1     54.83    0.24   Dazao
  GFD3     (S)-Coclaurine                                                                                                                                                 285.37   2.2     3      4      3     42.35    0.24   Dazao
  GFD4     21302-79-4                                                                                                                                                     486.76   4.53    3      5      3     73.52    0.77   Dazao
  GFD5     berberine                                                                                                                                                      336.39   3.75    0      4      2     36.86    0.78   Dazao
  GFD6     coumestrol                                                                                                                                                     268.23   2.43    2      5      0     32.49    0.34   Dazao
  GFD7     Fumarine                                                                                                                                                       353.4    1.95    0      6      0     59.26    0.83   Dazao
  GFD8     Jujubasaponin V_qt                                                                                                                                             472.78   4.61    2      4      2     36.99    0.63   Dazao
  GFD9     jujuboside A_qt                                                                                                                                                472.78   3.8     2      4      1     36.67    0.62   Dazao
  GFD10    Jujuboside C_qt                                                                                                                                                472.78   3.8     2      4      1     40.26    0.62   Dazao
  GFD11    malkangunin                                                                                                                                                    432.56   2.72    2      7      6     57.71    0.63   Dazao
  GFD12    Mauritine D                                                                                                                                                    342.46   1.11    2      6      2     89.13    0.45   Dazao
  GFD13    Moupinamide                                                                                                                                                    313.38   2.46    3      5      6     86.71    0.26   Dazao
  GFD14    Nuciferin                                                                                                                                                      295.41   3.38    0      3      2     34.43    0.4    Dazao
  GFD15    quercetin                                                                                                                                                      302.25   1.07    5      7      1     46.43    0.28   Dazao
  GFD16    Ruvoside_qt                                                                                                                                                    390.57   1.42    3      5      2     36.12    0.76   Dazao
  GFD17    Spiradine A                                                                                                                                                    311.46   1.29    1      3      0     113.52   0.61   Dazao
  GFD18    stepharine                                                                                                                                                     297.38   1.76    1      4      2     31.55    0.33   Dazao
  GFD19    Stepholidine                                                                                                                                                   327.41   2.26    2      5      2     33.11    0.54   Dazao
  GFD20    Ziziphin_qt                                                                                                                                                    472.78   3.8     2      4      1     66.95    0.62   Dazao
  GFD21    zizyphus saponin I_qt                                                                                                                                          472.78   3.8     2      4      1     32.69    0.62   Dazao
  GFD22    (-)-Medicocarpin                                                                                                                                               432.46   1.26    4      9      4     40.99    0.95   Gancao
  GFD23    (2R)-7-hydroxy-2-(4-hydroxyphenyl)chroman-4-one                                                                                                                256.27   2.79    2      4      1     71.12    0.18   Gancao
  GFD24    (2S)-6-(2,4-dihydroxyphenyl)-2-(2-hydroxypropan-2-yl)-4-methoxy-2,3-dihydrofuro\[3,2-g\]chromen-7-one                                                          384.41   2.61    3      7      3     60.25    0.63   Gancao
  GFD25    (2S)-7-hydroxy-2-(4-hydroxyphenyl)-8-(3-methylbut-2-enyl)chroman-4-one                                                                                         324.4    3.62    2      4      3     36.57    0.32   Gancao
  GFD26    (E)-1-(2,4-dihydroxyphenyl)-3-(2,2-dimethylchromen-6-yl)prop-2-en-1-one                                                                                        322.38   4.46    2      4      3     39.62    0.35   Gancao
  GFD27    (E)-3-\[3,4-dihydroxy-5-(3-methylbut-2-enyl)phenyl\]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one                                                                    340.4    3.47    4      5      5     46.27    0.31   Gancao
  GFD28    1,3-dihydroxy-8,9-dimethoxy-6-benzofurano\[3,2-c\]chromenone                                                                                                   328.29   2.74    2      7      2     62.9     0.53   Gancao
  GFD29    1,3-dihydroxy-9-methoxy-6-benzofurano\[3,2-c\]chromenone                                                                                                       298.26   2.48    2      6      1     48.14    0.43   Gancao
  GFD30    18α-hydroxyglycyrrhetic acid                                                                                                                                   486.76   4.54    3      5      1     41.16    0.71   Gancao
  GFD31    1-Methoxyphaseollidin                                                                                                                                          354.43   3.66    2      5      3     69.98    0.64   Gancao
  GFD32    2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylbut-2-enyl)chromone                                                                                           354.38   2.99    4      6      3     44.15    0.41   Gancao
  GFD33    2-\[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano\[6,5-f\]chromen-3-yl\]-5-methoxyphenol                                                                             338.43   4.35    1      4      2     36.21    0.52   Gancao
  GFD34    3-(2,4-dihydroxyphenyl)-8-(1,1-dimethylprop-2-enyl)-7-hydroxy-5-methoxy-coumarin                                                                               368.41   3.92    3      6      4     59.62    0.43   Gancao
  GFD35    3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)chromone                                                                                           354.38   3.02    4      6      3     66.37    0.41   Gancao
  GFD36    3'-Hydroxy-4'-O-Methylglabridin                                                                                                                                354.43   3.76    2      5      2     43.71    0.57   Gancao
  GFD37    3'-Methoxyglabridin                                                                                                                                            354.43   3.76    2      5      2     46.16    0.57   Gancao
  GFD38    5,7-dihydroxy-3-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromone                                                                                               352.41   3.29    2      5      4     30.49    0.41   Gancao
  GFD39    6-prenylated eriodictyol                                                                                                                                       356.4    2.99    4      6      3     39.22    0.41   Gancao
  GFD40    7,2',4'-trihydroxy-5-methoxy-3-arylcoumarin                                                                                                                    300.28   2.51    3      6      2     83.71    0.27   Gancao
  GFD41    7-Acetoxy-2-methylisoflavone                                                                                                                                   294.32   3.41    0      4      3     38.92    0.26   Gancao
  GFD42    7-Methoxy-2-methyl isoflavone                                                                                                                                  266.31   3.48    0      3      2     42.56    0.2    Gancao
  GFD43    8-(6-hydroxy-2-benzofuranyl)-2,2-dimethyl-5-chromenol                                                                                                          308.35   4.27    2      4      1     58.44    0.38   Gancao
  GFD44    8-prenylated eriodictyol                                                                                                                                       356.4    2.99    4      6      3     53.79    0.4    Gancao
  GFD45    Calycosin                                                                                                                                                      284.28   2.82    2      5      2     47.75    0.24   Gancao
  GFD46    dehydroglyasperins C                                                                                                                                           340.4    3.11    4      5      3     53.82    0.37   Gancao
  GFD47    DFV                                                                                                                                                            256.27   2.79    2      4      1     32.76    0.18   Gancao
  GFD48    echinatin                                                                                                                                                      270.3    3.41    2      4      4     66.58    0.17   Gancao
  GFD49    Eurycarpin A                                                                                                                                                   338.38   3.29    3      5      3     43.28    0.37   Gancao
  GFD50    formononetin                                                                                                                                                   268.28   3.01    1      4      2     69.67    0.21   Gancao
  GFD51    Gancaonin A                                                                                                                                                    352.41   3.34    2      5      4     51.08    0.4    Gancao
  GFD52    Gancaonin B                                                                                                                                                    368.41   3.14    3      6      4     48.79    0.45   Gancao
  GFD53    Gancaonin G                                                                                                                                                    352.41   3.25    2      5      4     60.44    0.39   Gancao
  GFD54    Gancaonin H                                                                                                                                                    420.49   3.99    3      6      3     50.1     0.78   Gancao
  GFD55    Glabranin                                                                                                                                                      324.4    3.59    2      4      3     52.9     0.31   Gancao
  GFD56    Glabrene                                                                                                                                                       322.38   3.68    2      4      1     46.27    0.44   Gancao
  GFD57    Glabridin                                                                                                                                                      324.4    3.81    2      4      1     53.25    0.47   Gancao
  GFD58    Glabrone                                                                                                                                                       336.36   3.78    2      5      1     52.51    0.5    Gancao
  GFD59    Glepidotin A                                                                                                                                                   338.38   2.88    3      5      3     44.72    0.35   Gancao
  GFD60    Glepidotin B                                                                                                                                                   340.4    2.88    3      5      3     64.46    0.34   Gancao
  GFD61    glyasperin B                                                                                                                                                   370.43   3.14    3      6      4     65.22    0.44   Gancao
  GFD62    Glyasperin C                                                                                                                                                   356.45   3.53    3      5      4     45.56    0.4    Gancao
  GFD63    glyasperin F                                                                                                                                                   354.38   3.52    3      6      1     75.84    0.54   Gancao
  GFD64    Glyasperins M                                                                                                                                                  368.41   3.57    2      6      2     72.67    0.59   Gancao
  GFD65    Glycyrin                                                                                                                                                       382.44   3.78    2      6      5     52.61    0.47   Gancao
  GFD66    Glycyrol                                                                                                                                                       366.39   4.06    2      6      3     90.78    0.67   Gancao
  GFD67    Glycyrrhiza flavonol A                                                                                                                                         370.38   2.18    4      7      1     41.28    0.6    Gancao
  GFD68    Glypallichalcone                                                                                                                                               284.33   3.8     1      4      5     61.6     0.19   Gancao
  GFD69    Glyzaglabrin                                                                                                                                                   298.26   2.32    2      6      1     61.07    0.35   Gancao
  GFD70    HMO                                                                                                                                                            268.28   2.92    1      4      2     38.37    0.21   Gancao
  GFD71    Inermine                                                                                                                                                       284.28   2.19    1      5      0     75.18    0.54   Gancao
  GFD72    Inflacoumarin A                                                                                                                                                322.38   4.36    2      4      3     39.71    0.33   Gancao
  GFD73    Isoglycyrol                                                                                                                                                    366.39   4.15    1      6      1     44.7     0.84   Gancao
  GFD74    Isolicoflavonol                                                                                                                                                354.38   2.92    4      6      3     45.17    0.42   Gancao
  GFD75    isoliquiritigenin                                                                                                                                              256.27   3.04    3      4      3     85.32    0.15   Gancao
  GFD76    isorhamnetin                                                                                                                                                   316.28   1.31    4      7      2     49.6     0.31   Gancao
  GFD77    Isotrifoliol                                                                                                                                                   298.26   2.54    2      6      1     31.94    0.42   Gancao
  GFD78    Jaranol                                                                                                                                                        314.31   2.8     2      6      3     50.83    0.29   Gancao
  GFD79    kaempferol                                                                                                                                                     286.25   1.23    4      6      1     41.88    0.24   Gancao
  GFD80    kanzonols W                                                                                                                                                    336.36   3.97    2      5      1     50.48    0.52   Gancao
  GFD81    Licoagrocarpin                                                                                                                                                 338.43   3.94    1      4      3     58.81    0.58   Gancao
  GFD82    Licoagroisoflavone                                                                                                                                             336.36   2.95    2      5      2     57.28    0.49   Gancao
  GFD83    licochalcone a                                                                                                                                                 338.43   4.74    2      4      6     40.79    0.29   Gancao
  GFD84    Licochalcone B                                                                                                                                                 286.3    3.17    3      5      4     76.76    0.19   Gancao
  GFD85    licochalcone G                                                                                                                                                 354.43   4.21    3      5      6     49.25    0.32   Gancao
  GFD86    Licocoumarone                                                                                                                                                  340.4    4.1     3      5      4     33.21    0.36   Gancao
  GFD87    licoisoflavanone                                                                                                                                               354.38   3.54    3      6      1     52.47    0.54   Gancao
  GFD88    Licoisoflavone                                                                                                                                                 354.38   2.99    4      6      3     41.61    0.42   Gancao
  GFD89    Licoisoflavone B                                                                                                                                               352.36   3.54    3      6      1     38.93    0.55   Gancao
  GFD90    licopyranocoumarin                                                                                                                                             384.41   2.47    3      7      3     80.36    0.65   Gancao
  GFD91    Licoricone                                                                                                                                                     382.44   3.08    2      6      5     63.58    0.47   Gancao
  GFD92    liquiritin                                                                                                                                                     418.43   0.43    5      9      4     65.69    0.74   Gancao
  GFD93    Lupiwighteone                                                                                                                                                  338.38   3.23    3      5      3     51.64    0.37   Gancao
  GFD94    Medicarpin                                                                                                                                                     270.3    3.07    1      4      1     49.22    0.34   Gancao
  GFD95    naringenin                                                                                                                                                     272.27   2.47    3      5      1     59.29    0.21   Gancao
  GFD96    Odoratin                                                                                                                                                       314.31   2.81    2      6      3     49.95    0.3    Gancao
  GFD97    Phaseol                                                                                                                                                        336.36   4.59    2      5      2     78.77    0.58   Gancao
  GFD98    Phaseolinisoflavan                                                                                                                                             324.4    3.77    2      4      1     32.01    0.45   Gancao
  GFD99    Pinocembrin                                                                                                                                                    256.27   2.85    2      4      1     64.72    0.18   Gancao
  GFD100   Quercetin der.                                                                                                                                                 330.31   2.55    3      7      3     46.45    0.33   Gancao
  GFD101   Semilicoisoflavone B                                                                                                                                           352.36   3.55    3      6      1     48.78    0.55   Gancao
  GFD102   shinpterocarpin                                                                                                                                                322.38   4.13    1      4      0     80.3     0.73   Gancao
  GFD103   Sigmoidin-B                                                                                                                                                    356.4    3.02    4      6      3     34.88    0.41   Gancao
  GFD104   Vestitol                                                                                                                                                       272.32   2.89    2      4      2     74.66    0.21   Gancao
  GFD105   ent-Epicatechin                                                                                                                                                290.29   2.83    5      6      1     48.96    0.24   Guizhi
  GFD106   beta-sitosterol                                                                                                                                                414.79   3.2     1      1      6     36.91    0.75   Guizhi
  GFD107   sitosterol                                                                                                                                                     414.79   2.71    1      1      6     36.91    0.75   Guizhi
  GFD108   (-)-taxifolin                                                                                                                                                  304.27   1.66    5      7      1     60.51    0.27   Guizhi
  GFD109   DMEP                                                                                                                                                           282.32   1.93    0      6      10    55.66    0.15   Guizhi
  GFD110   6-gingerol                                                                                                                                                     294.43   3.45    2      4      10    35.64    0.16   Shengjiang
  GFD111   6-shogaol                                                                                                                                                      276.41   4.95    1      3      9     31       0.14   Shengjiang
  GFD112   (R)-Norcoclaurine                                                                                                                                              271.34   1.73    4      4      2     82.54    0.21   Fuzi
  GFD113   6-Demethyldesoline                                                                                                                                             453.64   -0.53   4      8      5     51.87    0.66   Fuzi
  GFD114   benzoylnapelline                                                                                                                                               463.67   2.9     2      5      4     34.06    0.53   Fuzi
  GFD115   Deltoin                                                                                                                                                        328.39   2.95    0      5      4     46.69    0.37   Fuzi
  GFD116   Deoxyandrographolide                                                                                                                                           334.5    2.71    2      4      4     56.3     0.31   Fuzi
  GFD117   ignavine                                                                                                                                                       449.59   0.72    3      6      3     84.08    0.25   Fuzi
  GFD118   isotalatizidine                                                                                                                                                407.61   0.41    3      6      4     50.82    0.73   Fuzi
  GFD119   karakoline                                                                                                                                                     377.58   0.8     3      5      2     51.73    0.73   Fuzi
  GFD120   Karanjin                                                                                                                                                       292.3    3.42    0      4      2     69.56    0.34   Fuzi
  HGWD1    (+)-catechin                                                                                                                                                   290.29   1.02    5      6      1     54.83    0.24   Baishao
  HGWD2    (3S,5R,8R,9R,10S,14S)-3,17-dihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9-hexahydro-1H-cyclopenta\[a\]phenanthrene-15,16-dione                                  358.52   3.52    2      4      0     43.56    0.53   Baishao
  HGWD3    11alpha,12alpha-epoxy-3beta-23-dihydroxy-30-norolean-20-en-28,12beta-olide                                                                                     470.71   3.82    2      5      1     64.77    0.38   Baishao
  HGWD4    albiflorin_qt                                                                                                                                                  318.35   0.53    2      6      4     66.64    0.33   Baishao
  HGWD5    kaempferol                                                                                                                                                     286.25   1.23    4      6      1     41.88    0.24   Baishao
  HGWD6    Lactiflorin                                                                                                                                                    462.49   0.31    3      10     5     49.12    0.8    Baishao
  HGWD7    paeoniflorgenone                                                                                                                                               318.35   0.86    1      6      4     87.59    0.37   Baishao
  HGWD8    paeoniflorin_qt                                                                                                                                                318.35   0.69    2      6      4     68.18    0.4    Baishao
  HGWD9    (-)-catechin                                                                                                                                                   290.29   1.02    5      6      1     49.68    0.24   Dazao
  HGWD10   (S)-Coclaurine                                                                                                                                                 285.37   2.2     3      4      3     42.35    0.24   Dazao
  HGWD11   21302-79-4                                                                                                                                                     486.76   4.53    3      5      3     73.52    0.77   Dazao
  HGWD12   berberine                                                                                                                                                      336.39   3.75    0      4      2     36.86    0.78   Dazao
  HGWD13   coumestrol                                                                                                                                                     268.23   2.43    2      5      0     32.49    0.34   Dazao
  HGWD14   Fumarine                                                                                                                                                       353.4    1.95    0      6      0     59.26    0.83   Dazao
  HGWD15   Jujubasaponin V_qt                                                                                                                                             472.78   4.61    2      4      2     36.99    0.63   Dazao
  HGWD16   jujuboside A_qt                                                                                                                                                472.78   3.8     2      4      1     36.67    0.62   Dazao
  HGWD17   Jujuboside C_qt                                                                                                                                                472.78   3.8     2      4      1     40.26    0.62   Dazao
  HGWD18   malkangunin                                                                                                                                                    432.56   2.72    2      7      6     57.71    0.63   Dazao
  HGWD19   Mauritine D                                                                                                                                                    342.46   1.11    2      6      2     89.13    0.45   Dazao
  HGWD20   Moupinamide                                                                                                                                                    313.38   2.46    3      5      6     86.71    0.26   Dazao
  HGWD21   Nuciferin                                                                                                                                                      295.41   3.38    0      3      2     34.43    0.4    Dazao
  HGWD22   quercetin                                                                                                                                                      302.25   1.07    5      7      1     46.43    0.28   Dazao
  HGWD23   Ruvoside_qt                                                                                                                                                    390.57   1.42    3      5      2     36.12    0.76   Dazao
  HGWD24   Spiradine A                                                                                                                                                    311.46   1.29    1      3      0     113.52   0.61   Dazao
  HGWD25   stepharine                                                                                                                                                     297.38   1.76    1      4      2     31.55    0.33   Dazao
  HGWD26   Stepholidine                                                                                                                                                   327.41   2.26    2      5      2     33.11    0.54   Dazao
  HGWD27   Ziziphin_qt                                                                                                                                                    472.78   3.8     2      4      1     66.95    0.62   Dazao
  HGWD28   zizyphus saponin I_qt                                                                                                                                          472.78   3.8     2      4      1     32.69    0.62   Dazao
  HGWD29   ent-Epicatechin                                                                                                                                                290.29   2.83    5      6      1     48.96    0.24   Guizhi
  HGWD30   beta-sitosterol                                                                                                                                                414.79   3.2     1      1      6     36.91    0.75   Guizhi
  HGWD31   sitosterol                                                                                                                                                     414.79   2.71    1      1      6     36.91    0.75   Guizhi
  HGWD32   (-)-taxifolin                                                                                                                                                  304.27   1.66    5      7      1     60.51    0.27   Guizhi
  HGWD33   DMEP                                                                                                                                                           282.32   1.93    0      6      10    55.66    0.15   Guizhi
  HGWD34   6-gingerol                                                                                                                                                     294.43   3.45    2      4      10    35.64    0.16   Shengjiang
  HGWD35   6-shogaol                                                                                                                                                      276.41   4.95    1      3      9     31       0.14   Shengjiang
  HGWD36   (6aR,11aR)-9,10-dimethoxy-6a,11a-dihydro-6H-benzofurano\[3,2-c\]chromen-3-ol                                                                                   300.33   2.88    1      5      2     64.26    0.42   Huangqi
  HGWD37   1,7-Dihydroxy-3,9-dimethoxy pterocarpene                                                                                                                       314.31   2.85    2      6      2     39.05    0.48   Huangqi
  HGWD38   3,9-di-O-methylnissolin                                                                                                                                        314.36   3.28    0      5      3     53.74    0.48   Huangqi
  HGWD39   7-O-methylisomucronulatol                                                                                                                                      316.38   2.85    1      5      4     74.69    0.3    Huangqi
  HGWD40   Bifendate                                                                                                                                                      418.38   1.75    0      10     7     31.1     0.67   Huangqi
  HGWD41   Calycosin                                                                                                                                                      284.28   2.82    2      5      2     47.75    0.24   Huangqi
  HGWD42   formononetin                                                                                                                                                   268.28   3.01    1      4      2     69.67    0.21   Huangqi
  HGWD43   isoflavanone                                                                                                                                                   316.33   2.76    2      6      3     109.99   0.3    Huangqi
  HGWD44   isorhamnetin                                                                                                                                                   316.28   1.31    4      7      2     49.6     0.31   Huangqi
  HGWD45   Jaranol                                                                                                                                                        314.31   2.8     2      6      3     50.83    0.29   Huangqi
  HGWD46   9,10-dimethoxypterocarpan-3-O-β-D-glucoside                                                                                                                    462.49   1.18    4      10     5     36.74    0.92   Huangqi
  HGWD47   (Z)-1-(2,4-dihydroxyphenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one                                                                                                 256.27   3.04    3      4      3     87.51    0.15   Huangqi
  HGWD48   (3R)-3-(2-hydroxy-3,4-dimethoxyphenyl)chroman-7-ol                                                                                                             302.35   2.76    2      5      3     67.67    0.26   Huangqi

![Distribution map of active components in DSD, GFD, and HGWD.](fphar-11-01035-g002){#f2}

C-T Network Construction {#s3_3}
------------------------

To facilitate analysis of the complex relationships between active components and their targets of three formulas, component-target networks were constructed by using Cytoscape ([**Figures S1--S3**](#SM1){ref-type="supplementary-material"}). The results revealed that the DSD network consisted of 124 active components, 846 target proteins, and 3758 interactions; the GFD network contained120 active components, 821 target proteins, and 3759 interactions; the HGWD network consisted of 48 active components, 612 target proteins, and 1373 interactions.

We further analyzed the topology parameters of these C-T networks using NetworkAnalyzer and found that the average degree of components and targets in DSD were 30.31 and 5.20; the average degree of components and targets in GFD were 31.33 and 5.36; the average degree of components and targets in HGWD were 28.6 and 2.43. These results indicate that there exist interactions between one component and multiple targets in three formulas, and also exist phenomenon that different components act on the same target, which is in line with the characteristics of multi-component and multi-target mediated synergistic effect of TCM, and also reflects the complexity of the mechanism of TCM.

KNMSs Predication and Validation {#s3_4}
--------------------------------

### KNMSs Predication {#s3_4_1}

These C-T networks are complex and huge. How to quickly extract important information from these complex networks is the key step to decode underlying molecular mechanism. Here, we introduced the infomap algorithm in the network pharmacology model for the first time based on the random walk theory combined with Huffman-encoding. The algorithm performs to optimize the discovery of KNMSs in C-T network heuristically by using a reasonable global metric. 7, 10, and 10 KNMSs were predicted in DSD, GFD, and HGWD, respectively (p value \< 0.05) ([**Figures 3**](#f3){ref-type="fig"}--[**5**](#f5){ref-type="fig"}). The detail information of network KNMSs were shown in [**Table S2**](#SM1){ref-type="supplementary-material"}.

![The predicated KNMSs of C-T network of DSD. The red nodes represent the specific components of DSD, and the yellow nodes represent related targets.](fphar-11-01035-g003){#f3}

![The predicated KNMSs of C-T network of GFD. The green nodes represent the specific components of GFD, and the yellow nodes represent related targets.](fphar-11-01035-g004){#f4}

![The predicated KNMSs of C-T network of HGWD. The blue nodes represent the specific components of HGWD, and the yellow nodes represent related targets.](fphar-11-01035-g005){#f5}

### KNMSs Validation {#s3_4_2}

In order to validate whether predicted KNMSs in each formula can represent corresponding full C-T networks in treating RA. Three strategies were used to verify the accuracy and reliability and of KNMSs. The first strategy was used to see whether the number of RA pathogenic genes in KNMSs are close to the number of RA pathogenic genes in CT network. The coverage was defined as the percentage of the number of pathogenic genes in KNMSs to the number of pathogenic genes in C-T network. High coverage indicated that KNMSs could retain most formula-targeted RA pathogenic genes that included in the corresponding C-T network. The second strategy was designed to see whether the gene enrichment pathways in KNMSs covers the gene enrichment pathways in C-T network as much as possible. High coverage indicated that KNMSs could cover most genes enriched pathways of the corresponding C-T network. The third strategy was employed to calculate the percentage of cumulative contribution of important nodes in KNMSs to that of nodes in C-T network. High percentage means KNMSs can retain the important nodes in the corresponding C-T network. The detail results are as follows:

#### Validated the Number and Coverage of Pathogenic Genes in KNMSs {#s3_4_2_1}

To assess whether the number of RA pathogenic genes in KNMSs are close to the number of RA pathogenic genes in corresponding C-T network. The known pathogenic genes of RA reported by published literature and databases were collected, and the pathogenic genes confirmed by more than 5 literatures were selected for further analysis ([**Table S3**](#SM1){ref-type="supplementary-material"}). We found that the C-T network of DSD, GFD, and HGWD contains 50, 52, and 39 pathogenic genes, respectively. While the KNMSs of DSD, GFD, and HGWD contains 39, 40, and 30 pathogenic genes. The number of pathogenic genes in KNMSs compared to that in C-T network of DSD, GFD, and HGWD reached 78%, 76.9%, and 76.9%, which confirmed that the predicted KNMSs with high coverage of pathogenic genes ([**Figures 6A--C**](#f6){ref-type="fig"}). These results demonstrate that KNMSs have a high coincidence degree with C-T network in the number and coverage of pathogenic genes, it also indicated that our proposed KNMS detection model can maximize the coincidence degree of pathogenic genes in the C-T network of formulas.

![The number of overlap pathogenic genes between C-T network and KNMSs in DSD, GFD and HGWD **(A--C)**. **(A--C)** use venn diagram to visualize the overlap number between C-T network and KNMSs in DSD, GFD, and HGWD, respectively.](fphar-11-01035-g006){#f6}

#### Validated the Genes Enriched Pathways in KNMSs {#s3_4_2_2}

An additional metric for evaluating the importance of the inferred motifs is determined by their functional coherence, which can be accessed *via* their related genes enrichment pathways from KEGG ([@B24]). Here, we used this method to detect whether KNMSs found in each formula can represent their full C-T networks at functional level. Our analysis shown that genes enriched pathways of KNMSs in DSD accounts for 85.8% of genes enriched pathways of the full C-T network in DSD; genes enriched pathways of KNMSs in GFD accounts for 86.6% genes enriched pathways of the full C-T network in GFD; genes enriched pathways of KNMSs in HGWD accounts for 81.9% genes enriched pathways of the full C-T network in HGWD ([**Figures 7A, B**](#f7){ref-type="fig"}). It was encouraged that the gene enriched pathways involved in KNMSs of 3 formulas are highly compatible with gene enriched pathways of their C-T networks. This result confirmed that KNMSs have a high coincidence degree with C-T network at the gene functional level and also suggested that our proposed KNMS detection model can maximize the retention of functional pathways in the formulas of TCM.

![The functional similarity analysis between C-T network and KNMSs in DSD, GFD, and HGWD, respectively. **(A, B)** represent the functional similarity visualized by venn diagram and bubble diagram, respectively.](fphar-11-01035-g007){#f7}

#### Validated the Cumulative Contribution of Important Nodes in KNMSs {#s3_4_2_3}

The degree of nodes is a key topological parameter that characterizes the influence of nodes in a network ([@B36]). Here, a mathematical model was established to evaluate the importance of KNMSs in each formula based on the degree of nodes. According to the calculation results, each KNMS was assigned a CC value. The detailed information was shown in [**Figure 8**](#f8){ref-type="fig"} and [**Table S4**](#SM1){ref-type="supplementary-material"}. The sum of CC of 7, 10, and 10 KNMSs in each formula reached 80.44%, 79.88%, and 70.76% of that in C-T networks of DSD, GFD, and HGWD, respectively. The results confirmed that KNMSs have a high coincidence degree with C-T network on the topological structure and also indicated that our proposed KNMS detection model could maximize the coverage of important network topological structures compared with C-T network in each formula.

![The contribution coefficient of network topological between C-T network and KNMSs in DSD, GFD and HGWD **(A--C)**. **(A--C)** use bar diagram to visualize the cumulative contribution rate between C-T network and KNMSs in DSD, GFD and HGWD, respectively.](fphar-11-01035-g008){#f8}

Potential Mechanisms Analysis of Different Formulas Treats the Same Disease {#s3_5}
---------------------------------------------------------------------------

In order to reveal the potential mechanism of KNMSs in different formula for treating rheumatoid arthritis, pathway enrichment analysis of KNMS-related genes in each formula were performed. In the DSD, genes in total 7 KNMSs were enriched in 165 pathways, genes in two KNMSs, DSD1, and DSD2 were enriched in 158 pathways, accounting for 95.8% of that in 7 KNMSs. The arthritis-related signaling pathways corresponding to DSD1 and DSD2 were partially complementary, for example, genes in DSD1 were mainly enriched in JAK-STAT signaling pathway and AMPK signaling pathway, genes in DSD2 mainly enriched in NF-kappa B signaling pathway, p53 signaling pathway and Wnt signaling pathway. In GFD, we total got 10 KNMSs. Genes in these 10 KNMSs were enriched in 151 pathways. Four of 10 KNMSs, GFD1, GFD3, GFD4, and GFD5 related genes are enriched in 144 pathways, accounting for 95.4% of enrichment pathways in 10 KNMSs of GFD. Moreover, some of their corresponding arthritis-related signaling pathways are complementary. For example, GFD1 mainly includes TNF signaling pathway, IL-17 signaling pathway and AMPK signaling pathway, and GFD3 mainly includes Inflammatory mediator regulation of TRP channels and GnRH signaling pathway. In HGWD, genes in 10 predicted KNMSs were enriched in 110 pathways, genes in HGWD4 and HGWD5, HGWD6, and HGWD8 covered 102 pathways, accounting for 92.7% of all KNMSs gene enrichment pathways. Consistent with DSD and GFD results, some of their corresponding arthritis-related signal pathways were also complementary. For example, HGWD4 mainly includes TNF signaling pathway, Hedgehog signaling pathway and IL-17 signaling pathway, HGWD5 mainly includes VEGF signaling pathway, NF-kappa B signaling pathway and mTOR signaling pathway, HGWD6 mainly includes cAMP signaling pathway and cGMP-PKG signaling pathway ([**Figure 9**](#f9){ref-type="fig"}, [**Table S5**](#SM1){ref-type="supplementary-material"}). These results show that KNMSs in different formulas have distinct roles and synergistic effects in the treatment of rheumatoid arthritis.

![The enrichment pathway map of KNMSs in the C-T network of DSD, GFD, and HGWD.](fphar-11-01035-g009){#f9}

In order to further explore the potential mechanism of the three formulas in treating RA, besides the difference analysis of each KNMS in different formulas, KEGG enrichment analysis of all KNMSs in each formula were also implemented and found that 3 formulas play the therapeutic effect on RA through the following five common pathways: Rap1 signaling pathway, cAMP signaling pathway, MAPK signaling pathway, EGFR Tyrosine Kinase Inhibitor Resistance, Calcium signaling pathway and Neuroactive ligand-receptor interaction. Except the common pathways, we found that the three formulas can play the role of treating RA through their specific pathways ([**Figure 10**](#f10){ref-type="fig"}). For example, DSD can play the role of treating RA by regulating VEGF signaling pathway. GFD can play a role in treating RA by regulating HIF-1 signaling pathway. HGWD can play a role in treating RA by regulating PI3K-Akt signaling pathway. These results indicate that 3 formulas can play the role of treating RA through different and common pathways, which may act as the essence of different formulas treat the same disease.

![Gene enrichment analysis of all KNMSs from DSD, GFD, and HGWD, respectively.](fphar-11-01035-g010){#f10}

Through PubMed literature search, we found that among the common pathways, MAPK signaling pathway and cAMP signaling pathway have the most correlation records with rheumatoid arthritis. We selected MAPK signaling pathway and cAMP signaling pathway which were reported closely related to inflammation to illustrate the mechanism of different formulas treat the same disease in detail. Firstly, a comprehensive inflammatory pathway was constructed by integrating the two pathways. And then, the genes in KNMSs of three formulas were mapped to the comprehensive inflammatory pathway ([**Figure 11**](#f11){ref-type="fig"}). Results show that genes in the KNMSs of DSD mainly distributed in the downstream of the comprehensive inflammatory pathway, such as MAPK14, MAPK8, and JUND; Genes in the KNMSs of GFD mainly distributed in the downstream of the comprehensive inflammatory pathway, such as AKT3, RAF1, and TAOK3; while genes in the KNMSs of HGWD distributed both in the upstream and downstream of the comprehensive inflammatory pathway, such as CSF1R, ADCYAP1R1, CHRM1, NFKB1, MAPT, and JUN. The results suggest that different formulas play therapeutic roles through targeting different genes in the comprehensive inflammatory pathway.

![Distribution of specific targets enriched pathways of KNMSs in three formulas on the comprehensive inflammatory pathway. **(A--C)** represent the distribution of targets enriched pathways of KNMSs in DSD, GFD and HGWD on the comprehensive inflammatory pathway, respectively.](fphar-11-01035-g011){#f11}

Experimental Validation *In Vitro* {#s3_6}
----------------------------------

Effects of isoliquiritigenin, isorhamnetin and quercetin with different concentrations on cell viabilities of RAW264.7 cells were detected by MTT assay. Compared with control group, 1, 5, 10, and 20 μM isoliquiritigenin, isorhamnetin, and quercetin had no effects on RAW264.7 cells viabilities ([**Figures 12A--C**](#f12){ref-type="fig"}). Therefore, four concentrations were used (1, 5, 10, and 20 μM) for subsequent experiments.

![Effects of isoliquiritigenin **(A, D)**, isorhamnetin **(B, E)**, and quercetin **(C, F)** on cell viabilities and NO of LPS induced RAW264.7 cells. ^\*^p \< 0.05, ^\*\*^p \< 0.01, ^\*\*\*^p \< 0.001 compared with control group. ^\#^p \< 0.05, ^\#\#\#^p \< 0.001 compared with the LPS group.](fphar-11-01035-g012){#f12}

NO is a regulator of information transmission between cells and has the function of mediating cellular immune and inflammatory reactions. In order to further evaluate the results obtained by the network pharmacology model, the key components in KNMSs of each formula were selected for experimental validation. Isoliquiritigenin from motif 1 (DSD1) of DSD, isorhamnetin from motif 1 (GFD1) of GFD, and quercetin from motif 5 (HGWD5) of HGWD were chose to detect potential anti-inflammatory effects using LPS induced RAW264.7 cells. Compared with control group, the NO level was significantly increased by 275.34% in the culture medium of LPS treated cells, however, isoliquiritigenin (10 and 20 μM) markedly decreased the extracellular NO levels by 107.94% and 151.04%, isorhamnetin (10 and 20 μM) markedly decreased the extracellular NO levels by 81.59% and 137.94%, quercetin (5, 10 and 20 μM) markedly decreased the extracellular NO levels by 56.68%, 106.57% and 174.59%, respectively, in a concentration-dependent manner ([**Figures 12D--F**](#f12){ref-type="fig"}). Our results demonstrated that isoliquiritigenin, isorhamnetin, and quercetin inhibited NO production in LPS induced RAW264.7 cells.

Discussion {#s4}
==========

The therapeutic effect of current synthetic agents in treating RA is not satisfactory and most of them have undesirable side effects. In China, some classical formulas have a long history of clinical application to treat RA and have shown significant curative effects. However, TCM formulas is a multi-component and multi-target agent from the molecular perspective ([@B10]; [@B3]). Based on the characteristics of complex components and unclear targets of TCM formula, the development of novel methods became an urgent issue needed to be solved.

TCM network pharmacology emerging recently has become a flourishing field in TCM modern studies along with the rapid progress of bioinformatics ([@B20]; [@B19]; [@B52]). So, using the method, combined with the rich experience of TCM treatment, could hopefully decode the underlying mechanism of TCM formula in the treatment of complex disease with the characteristic of "multi-targets, multi-component". Network pharmacology approach could help us search for putative active components and targets of herbs based on widely existing databases and shows the network of drug-targets by a visual way ([@B18]). Moreover, it abstracts the interaction between drugs and target genes into a network model and investigates the effects of drugs on biological networks from a holistic perspective. It can help us to further understand potential action mechanisms of TCM within the context of interactions at the system level. However, in the decode process of complex networks, there are still exist redundancies and noises in current network pharmacology study.

In order to solve this problem, we introduced the infomap algorithm based on huffman encoding and the random walk theory for the first time. The algorithm performs to optimize the discovery of motif in C-T network heuristically by using a reasonable global metric. The results of optimized KNMSs are used to analyze the mechanism of different formulas for the treatment of RA. During this process the contribution coefficient model was used to validate the predicted KNMSs, which confirm the accuracy and reliability of our proposed strategy.

In this study, 230 active components of three formulas were found in total after ADME screening, 31 of these components are common to the three formulas, and 93, 89, and 17 components are specific to each formula. It suggested that the three formulas play therapeutic effect on rheumatoid arthritis through both common and specific components. In order to analyze the key component groups and mechanisms of the three formulas in the treatment of rheumatoid arthritis, we used target prediction tools to predict the targets of active components in different formulas and construct C-T networks. The degree distribution in the C-T network shows that the same components could act on different targets, and different components could also act on the same targets, which fully reflects the multi-component and multi-target complexity of TCM in treating complex diseases.

In order to quickly extract important information from complex C-T networks, motif prediction and validation strategy were used to rapidly discover the KNMSs of different formulas in the treatment of RA by using multidimensional data. More and more evidences show that network motif is an effective method to extract functional units and find core elements in complex networks. Radicchi et al. has confirmed that network motif offers an effective and manageable approach for characterizing rapidly the main functional unit of disease progression ([@B41]). Yang has reported that identifying overlapping motifs is crucial for understanding the structure as well as the function of real-world networks ([@B60]). Cai et al. indicate that uncovering motif structures of a complex network can help us to understand how the network play functions ([@B5]). Utilizing the network motif prediction model, 7, 10, and 10 KNMSs (p\<0.05) were predicted in DSD, GFD and HGWD, respectively.

Coverage of RA pathogenic genes, coverage of functional pathways and cumulative contribution of key nodes were employed to evaluate the accuracy and reliability of KNMSs. The verification results show that KNMSs has a high coincidence degree with C-T network at the pathogenic genes, gene functional and topological structure level. It suggests that our proposed KNMS detection model can maximize the retention of functional pathways, the coverage of network topological structure and the coincidence degree of pathogenic genes in the formulas of TCM.

Through the analysis of KNMSs gene enrichment pathways in different formulas, we found that the percentage of gene enrichment pathways of different KNMSs is distinct compare to the gene enrichment pathways of all KNMSs in each formula. In DSD, gene enrichment pathways of DSD1, DSD2 account for more than 95% of gene enrichment pathways of 7 KNMSs. In GFD, the gene enrichment pathways of 4 KNMSs, GFD1, GFD3, GFD4, and GFD5 account for 95.4% of gene enrichment pathways of 10 KNMSs. In HGWD, the gene enrichment pathways of 4 KNMSs, HGWD4, HGWD5, HGWD6, and HGWD8 account for 92.7% of gene enrichment pathways of 10 KNMSs. These KNMSs in each formula play different roles by targeting on common and complementary inflammation-related signaling pathways. These complementary inflammatory signaling pathways include: DSD1 specifically related JAK-STAT signaling pathway and AMPK signaling pathway, DSD2 specifically related NF-kappa B signaling pathway, p53 signaling pathway and Wnt signaling pathway. GFD1 specifically related TNF signaling pathway, IL-17 signaling pathway, GFD3 specifically related Inflammatory mediator regulation of TRP channels and GnRH signaling pathway, HGWD4 specifically related TNF signaling pathway, Hedgehog signaling pathway, HGWD5 specifically related VEGF signaling pathway and mTOR signaling pathway, HGWD6 specifically related cAMP signaling pathway and cGMP-PKG signaling pathway. These results indicate that KNMSs in different formulas have distinct roles and synergistic effects in the treatment of rheumatoid arthritis.

In addition to the difference analysis of each KNMS in different formulas, KEGG enrichment analysis of all KNMSs in each formula were also implemented and revealed that 3 formulas exert the therapeutic effect of RA through common pathway, such as MAPK signaling pathway, cAMP signal pathway etc. or specific pathway, such as VEGF signaling pathway, HIF-1 signaling pathway, PI3K-Akt signaling pathway etc. Among them, MAPK signaling pathway plays an important role in the pathological process of RA ([@B45]). Its over-activation is closely related to inflammatory hyperplasia of synovial tissue and destruction of articular cartilage tissue. As an inducible transcription factor, MAPK regulates the expression of many genes and has been considered as a promising target for the treatment of RA ([@B43]). Studies have shown that collagen-induced arthritis rats administrated with MAPK signal transduction pathway inhibitor have significant differences in inhibiting synovitis, bone destruction and articular cartilage destruction compared with the group without signal pathway inhibitor ([@B1]). cAMP signal pathway is an important signal pathway for peripheral blood lymphocytes of RA patients. The study found that the cAMP level in peripheral blood lymphocytes (PBL) of RA patients increased, and its proliferation response was significantly lower than that of PBL in normal patients. It was also found that the abnormal activation of adenylate cyclase in RA patients was related to the low function of Gi protein ([@B11]). The formation of RA neovascularization depends on the expression of various angiogenic factors, especially VEGF and its receptor in RA ([@B37]). It has been confirmed that VEGF expression is upregulated in synovial macrophages and fibroblasts of RA patients, and VEGF expression is positively correlated with RA disease activity and joint destruction ([@B23]). The articular cavity of RA is anoxic microenvironment. Recent studies have shown that the increased expression of HIF-1 in synovium of RA joint is closely related to the occurrence and development of RA ([@B57]). PI3K-AKT signal pathway is an important intracellular signal transduction pathway, which is closely related to abnormal apoptosis of RA fibroblast-like synovial cells (RAFLS) ([@B47]). Inhibition of abnormally activated PI3K-AKT signaling pathway or expression of anti-apoptotic molecules can induce apoptosis in RAFLS and have therapeutic effect on RA ([@B30]).

Besides the function analysis, we also analysis and validated the key components in KNMSs of each formula. In DSD, the results suggested that the key component isoliquiritigenin from motif 1 (DSD1) exert effect on treatment of RA possibly through acting on MAPK signaling pathway. Studies have shown that isoliquiritigenin suppresses RANKL-induced osteoclastogenesis and inflammatory bone loss *via* RANK-TRAF6, MAPK, IκBα/NF-κB, and AP-1 signaling pathways ([@B63]). In GFD, the results suggested that the key component isorhamnetin from motif 1 (GFD1) treats RA possibly through acting on TNF signaling pathway. Published reports confirmed that isorhamnetin play intervening roles in the development and progression of RA *via* anti-inflammatory and anti-oxidative activities. Previous studies have suggested that isorhamnetin attenuates collagen-induced arthritis *via* modulating the levels of cytokines TNF-α, IL-1β, and IL-6 etc. in the joint tissue homogenate of mice ([@B51]). In HGWD, the results suggested that the key component quercetin from motif 5 (HGWD5) has therapeutic effect on RA possibly through acting on PI3K-Akt signaling pathway. This also verified by previous studies, which found that the mechanisms responsible for the quercetin-induced apoptosis of FLS from patients with RA are associated with the inhibition of PI3K/AKT pathway activation ([@B39]). Cellular experiments were applied to prove the reliability of the network pharmacology model through verifying the protective effects of key components in KNMSs of three formulas on the inflammation of mice RAW264.7 cells induced by LPS. In addition, in order to better evaluate the reliability of our proposed network pharmacology model, *in vivo* study will be conducted in our future research.

To summarize, a network pharmacology-based approach was established to extract core components group and decode the mechanisms of different formulas treat the same disease of TCM. Additionally, our proposed KNMS prediction and validation strategy provides methodological reference for optimization of core components group and interpretation of the molecular mechanism in the treatment of complex diseases using TCM.
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